About this Project
Construction of a new medical research facility specializing in drug development for cancer immunotherapies in support of clinical trials in the United States according to U.S. Food and Drug Administration (FDA) guidelines.
The building includes ISO 7 & ISO 8 clean rooms with daylighting from building exterior, quality control and cell culture labs, and offices with attractive architectural elements. The project includes an accelerated schedule with early design packages for pre-purchasing equipment.